CD8+ cell depletion amplifies the acute retroviral syndrome

The duration and severity of the symptomatology present during the early phase of human immunodeficiency virus (HIV) infection (known as the acute retroviral syndrome) is associated with alterations in the clinical profile of infection, such as a shortening of duration between infection with HIV and...

Full description

Saved in:
Bibliographic Details
Published inJournal of neurovirology Vol. 10; no. s1; pp. 58 - 66
Main Authors Madden, Lisa J, Zandonatti, Michelle A, Flynn, Claudia T, Taffe, Mike A, Cecilia, M, Marcondes, G, Schmitz, Jörn E, Reimann, Keith A, Henriksen, Steven J, Fox, Howard S
Format Journal Article
LanguageEnglish
Published Informa UK Ltd 2004
Online AccessGet full text

Cover

Loading…
Abstract The duration and severity of the symptomatology present during the early phase of human immunodeficiency virus (HIV) infection (known as the acute retroviral syndrome) is associated with alterations in the clinical profile of infection, such as a shortening of duration between infection with HIV and the onset of neurocognitive impairment and acquired immunodeficiency syndrome (AIDS). Viral-specific CD8+ cytotoxic T lymphocytes (CTLs) and CD8+ natural killer (NK) cells play a key role in antiviral immunity. Loss of CD8+ cells or their functional impairment during the early period of infection is associated with a rapid progression to AIDS in nonhuman primate studies. However, no studies have determined whether CD8+ cell loss or impairment is associated with symptoms of acute retroviral illness such as fever. In this study, the authors compared the early phase of simian immunodeficiency virus (SIV) infection in animals that were treated with the anti-CD8 monoclonal antibody cM-T807 to deplete CD8+ cells during the early period of infection (SIV+ CD8− group) to those with intact CD8+ cells (SIV+ CD8+ group). The SIV+ CD8− group had an enhanced acute retroviral syndrome when compared to the SIV+ CD8+ group. The SIV+ CD8− group also had prolonged high viral loads and distinct alterations in the proinflammatory cytokines interleukin (IL)-6 and interferon (IFN)-α, as well as in monocyte chemoattractant protein (MCP)-1. CD8+ cell depletion, therefore, appears to enhance symptoms of the acute retroviral syndrome and alters several of the immunological factors associated with the early phase of infection.
AbstractList The duration and severity of the symptomatology present during the early phase of human immunodeficiency virus (HIV) infection (known as the acute retroviral syndrome) is associated with alterations in the clinical profile of infection, such as a shortening of duration between infection with HIV and the onset of neurocognitive impairment and acquired immunodeficiency syndrome (AIDS). Viral-specific CD8+ cytotoxic T lymphocytes (CTLs) and CD8+ natural killer (NK) cells play a key role in antiviral immunity. Loss of CD8+ cells or their functional impairment during the early period of infection is associated with a rapid progression to AIDS in nonhuman primate studies. However, no studies have determined whether CD8+ cell loss or impairment is associated with symptoms of acute retroviral illness such as fever. In this study, the authors compared the early phase of simian immunodeficiency virus (SIV) infection in animals that were treated with the anti-CD8 monoclonal antibody cM-T807 to deplete CD8+ cells during the early period of infection (SIV+ CD8− group) to those with intact CD8+ cells (SIV+ CD8+ group). The SIV+ CD8− group had an enhanced acute retroviral syndrome when compared to the SIV+ CD8+ group. The SIV+ CD8− group also had prolonged high viral loads and distinct alterations in the proinflammatory cytokines interleukin (IL)-6 and interferon (IFN)-α, as well as in monocyte chemoattractant protein (MCP)-1. CD8+ cell depletion, therefore, appears to enhance symptoms of the acute retroviral syndrome and alters several of the immunological factors associated with the early phase of infection.
Author Schmitz, Jörn E
Zandonatti, Michelle A
Cecilia, M
Reimann, Keith A
Flynn, Claudia T
Madden, Lisa J
Fox, Howard S
Taffe, Mike A
Henriksen, Steven J
Marcondes, G
Author_xml – sequence: 1
  givenname: Lisa J
  surname: Madden
  fullname: Madden, Lisa J
  organization: 1Department of Neuropharmacology, The Scripps Research Institute, La Jolla, California, USA
– sequence: 2
  givenname: Michelle A
  surname: Zandonatti
  fullname: Zandonatti, Michelle A
  organization: 1Department of Neuropharmacology, The Scripps Research Institute, La Jolla, California, USA
– sequence: 3
  givenname: Claudia T
  surname: Flynn
  fullname: Flynn, Claudia T
  organization: 1Department of Neuropharmacology, The Scripps Research Institute, La Jolla, California, USA
– sequence: 4
  givenname: Mike A
  surname: Taffe
  fullname: Taffe, Mike A
  organization: 1Department of Neuropharmacology, The Scripps Research Institute, La Jolla, California, USA
– sequence: 5
  givenname: M
  surname: Cecilia
  fullname: Cecilia, M
  organization: 1Department of Neuropharmacology, The Scripps Research Institute, La Jolla, California, USA
– sequence: 6
  givenname: G
  surname: Marcondes
  fullname: Marcondes, G
  organization: 1Department of Neuropharmacology, The Scripps Research Institute, La Jolla, California, USA
– sequence: 7
  givenname: Jörn E
  surname: Schmitz
  fullname: Schmitz, Jörn E
  organization: 1Department of Neuropharmacology, The Scripps Research Institute, La Jolla, California, USA
– sequence: 8
  givenname: Keith A
  surname: Reimann
  fullname: Reimann, Keith A
  organization: 1Department of Neuropharmacology, The Scripps Research Institute, La Jolla, California, USA
– sequence: 9
  givenname: Steven J
  surname: Henriksen
  fullname: Henriksen, Steven J
  organization: 1Department of Neuropharmacology, The Scripps Research Institute, La Jolla, California, USA
– sequence: 10
  givenname: Howard S
  surname: Fox
  fullname: Fox, Howard S
  organization: 1Department of Neuropharmacology, The Scripps Research Institute, La Jolla, California, USA
BookMark eNp1jztrwzAUhUVJoUnauav2YkeyHpHoVNwnBLq0s9HjmjjIcpCcQP59naZrp_st37nnLNAsDhEQuqekpESR1S4eJygzLYUqpbxCcyqYKirO2WxiJkRBKsVv0CLnHSGUyUrN0WP9rB6wgxCwh32AsRsiNv0-dG0HGY9bwMYdRsAJxjQcu2QCzqfo09DDLbpuTchw93eX6Pv15at-Lzafbx_106Zw0xNZOK8Ycb7lglmlgRPuNId15aYO1BGtha2Ecq4Ca63UWlmx9p4aTxS3Wkq2RKtLrktDzgnaZp-63qRTQ0lz3t5M28-caSNU82voi9HFdki92YIJ49aZBM1uOKQ4tf3X_QHFimLq
CitedBy_id crossref_primary_10_1186_s12865_016_0145_0
ContentType Journal Article
Copyright 2004 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2004
Copyright_xml – notice: 2004 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2004
DBID AAYXX
CITATION
DOI 10.1080/jnv.10.s1.58.66
DatabaseName CrossRef
DatabaseTitle CrossRef
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1538-2443
EndPage 66
ExternalDocumentID 10_1080_jnv_10_s1_58_66
GroupedDBID ---
-EM
-~C
.GJ
06D
0R~
0VY
203
29L
29~
2JN
2KG
2KM
2LR
2VQ
30V
34G
36B
39C
4.4
406
408
5GY
5VS
67N
8UJ
95.
96X
AAAVM
AABHQ
AAFGU
AAHNG
AAIAL
AAJKR
AANXM
AANZL
AARHV
AARTL
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAZMS
ABDZT
ABECU
ABFGW
ABFTV
ABHLI
ABIVO
ABJOX
ABKAS
ABKCH
ABMQK
ABPLI
ABPTK
ABQBU
ABSXP
ABTEG
ABTHY
ABTMW
ABULA
ABXPI
ACBMV
ACBRV
ACBYP
ACGEJ
ACGFS
ACHSB
ACHXU
ACIGE
ACIPQ
ACKNC
ACMDZ
ACMLO
ACOKC
ACTTH
ACVWB
ACWMK
ADCVX
ADHHG
ADHIR
ADINQ
ADKNI
ADKPE
ADMDM
ADRFC
ADTPH
ADURQ
ADXPE
ADYFF
ADZKW
AEBTG
AEFTE
AEGNC
AEJHL
AEJRE
AEKMD
AENEX
AEOHA
AEPYU
AESTI
AETCA
AEVTX
AEXYK
AFKVX
AFLOW
AFQWF
AFWTZ
AFZKB
AGAYW
AGDGC
AGGBP
AGJBK
AGMZJ
AGQMX
AGWZB
AGYKE
AHAVH
AHBYD
AHKAY
AHSBF
AHYZX
AIAKS
AIIXL
AILAN
AIMYW
AITGF
AJBLW
AJDOV
AJRNO
AJWEG
AJZVZ
AKMHD
AKQUC
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMYLF
AMYQR
ANMIH
AOCGG
ARMRJ
AWYRJ
AXYYD
BGNMA
CAG
COF
CS3
CSCUP
DNIVK
DU5
DX2
EBD
EBLON
EBS
EIOEI
EJD
EMB
EMOBN
EN4
ESBYG
F5P
FERAY
FIGPU
FINBP
FNLPD
FRP
FRRFC
FSGXE
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
H13
HF~
HMJXF
HRMNR
HZ~
IKXTQ
ITM
IWAJR
J-C
JBSCW
JZLTJ
KOV
LLZTM
M44
M4Y
NPVJJ
NQJWS
NU0
O9-
O93
O9I
O9J
OK1
P2P
PT4
R9I
RSV
S1Z
S27
S3A
S3B
SBL
SHX
SISQX
SNE
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
T13
TFW
TSG
U2A
U9L
UG4
UOJIU
UTJUX
UZXMN
VFIZW
W2D
W48
WK8
Z7U
Z87
ZMTXR
ZOVNA
53G
AACDK
AAJBT
AASML
AATNV
AAYXX
ABAKF
ABJNI
ABTKH
ACAOD
ACDTI
ACZOJ
AEFQL
AEMSY
AESKC
AEVLU
AFBBN
AGQEE
AGRTI
AIGIU
AMXSW
CITATION
DDRTE
DPUIP
ROL
SJYHP
SNPRN
TDBHL
ID FETCH-LOGICAL-c1366-cd830cdf453b89e404c94e72c0131c0995b258cc2ebbb6998b57dd1ad084b9663
ISSN 1355-0284
IngestDate Thu Sep 12 18:30:46 EDT 2024
Wed Jun 21 13:15:15 EDT 2023
IsPeerReviewed true
IsScholarly true
Issue s1
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c1366-cd830cdf453b89e404c94e72c0131c0995b258cc2ebbb6998b57dd1ad084b9663
PageCount 9
ParticipantIDs crossref_primary_10_1080_jnv_10_s1_58_66
informahealthcare_journals_10_1080_jnv_10_s1_58_66
PublicationCentury 2000
PublicationDate 20040000
2004-01-00
PublicationDateYYYYMMDD 2004-01-01
PublicationDate_xml – year: 2004
  text: 20040000
PublicationDecade 2000
PublicationTitle Journal of neurovirology
PublicationYear 2004
Publisher Informa UK Ltd
Publisher_xml – name: Informa UK Ltd
SSID ssj0013628
Score 1.6950145
Snippet The duration and severity of the symptomatology present during the early phase of human immunodeficiency virus (HIV) infection (known as the acute retroviral...
SourceID crossref
informahealthcare
SourceType Aggregation Database
Publisher
StartPage 58
Title CD8+ cell depletion amplifies the acute retroviral syndrome
Volume 10
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBbtBkovJX3RtEnQIYXC4q1lS7JMTtltQki6Oe1C6MVIsky2LdsSO4Xm12dm5VdekORihLFsrPk8Ho2--UTIDkvTnIU2CYTObcBdzIPUJSJIZVGg2olyFuudpyfycM6PTsVpb8UUq0sqM7KXd9aVPMWqcA7silWyj7Bse1M4AW2wLxzBwnB8kI0n39TnaDzE5DtSWlFHG8nFSBIvFqjdcIZiGcgEOHcV5g6wGv8ujYJeWLoSuMTit366fdr6p--LUndLST80bgaiK88JaGilwx4q_vv4ePJbXwASO0r2TBeFT4ovfjUdmuRDl3ZsiqXmxz36ETpQiF8CiFn8la5zqhBGxNe8bthDV8l6PtRLudd_Y78lyy0_74mRP5f_oDkq2UiokbyhqN1OcVABFa6ERlayTKhMyudkLQLHJAZkbe9gPD7p1p3kajfe9i0aMSgVfr3xsGtxzHqtcnvWcvZ6QcpsnbyqzUj3PFRek2du-Ya8mNb8ibdkFxAzpIgX2uKFtnihgBe6wgvt8EIbvLwj84P92eQwqLfPCCy8hwxsruLQ5gUXsVGp4yG3KXdJZFFiycLMQJhIKGsjZ4yRMO02IslzpvNQcQOz4Pg9GSz_LN0HQjnjrLBasJwnSEhWkmkbG1OkUujY2A3ypRmM7K9XScnuGfoNEt0arKz-psr7On18SqdP5KWnWWG-bJMMqvMLtwURZGW2a7NfAWuic3k
link.rule.ids 315,783,787,4031,27935,27936,27937
linkProvider Library Specific Holdings
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=CD8%2B+cell+depletion+amplifies+the+acute+retroviral+syndrome&rft.jtitle=Journal+of+neurovirology&rft.au=Madden%2C+Lisa+J&rft.au=Zandonatti%2C+Michelle+A&rft.au=Flynn%2C+Claudia+T&rft.au=Taffe%2C+Mike+A&rft.date=2004&rft.pub=Informa+UK+Ltd&rft.issn=1355-0284&rft.eissn=1538-2443&rft.volume=10&rft.issue=s1&rft.spage=58&rft.epage=66&rft_id=info:doi/10.1080%2Fjnv.10.s1.58.66&rft.externalDocID=10_1080_jnv_10_s1_58_66
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1355-0284&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1355-0284&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1355-0284&client=summon